PERFUSE THERAPEUTICS
Perfuse Therapeutics specializes in developing therapies for the treatment of eye disease. The company is pursuing a novel mechanism to treat various eye diseases, starting with glaucoma, by improving retinal perfusion.
PERFUSE THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Medical
Founded:
2018-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.perfusetherapeutics.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
9 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF LetsEncrypt Nginx Microsoft Exchange Online Office 365 Mail Unified Layer Google DNS Google Domains
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
AntiRadical Therapeutics
AntiRadical Therapeutics focuses on developing drugs for the treatment of blood flow disruption.
Electra Therapeutics
Electra Therapeutics is a clinical stage biotechnology company developing therapies for cancer and other immunological diseases.
Current Employees Featured
Founder
Investors List
OrbiMed
OrbiMed investment in Venture Round - Perfuse Therapeutics
Official Site Inspections
http://www.perfusetherapeutics.com
- Host name: box5917.bluehost.com
- IP address: 162.241.30.56
- Location: Provo United States
- Latitude: 40.2342
- Longitude: -111.6442
- Metro Code: 770
- Timezone: America/Denver
- Postal: 84606
More informations about "Perfuse Therapeutics"
Perfuse Therapeutics - Developing novel therapies to reduce …
Perfuse Therapeutics is developing a product to improve blood flow to the retina, the most metabolically demanding tissue in the human body.See details»
About Us - Perfuse Therapeutics
Michelle joined Perfuse in 2021 as the head of clinical development and translational sciences at Perfuse. She is a skilled clinical and translational leader with significant experience in ocular …See details»
Perfuse Therapeutics - Crunchbase Company Profile & Funding
Contact Email [email protected] Perfuse Therapeutics specializes in developing therapies for the treatment of eye disease. The company is pursuing a novel mechanism to …See details»
Contact - Perfuse Therapeutics
Corporate Headquarters: 611 Gateway Blvd., Suite 910 South San Francisco, CA 94080 [email protected]See details»
Perfuse Therapeutics 2025 Company Profile: Valuation, …
Www.perfusetherapeutics.com. Ownership Status. Privately Held (backing) Financing Status. Venture Capital-Backed. Corporate Office. 611 Gateway …See details»
Perfuse Therapeutics - Overview, News & Similar companies
Apr 4, 2023 View Perfuse Therapeutics (www.perfusetherapeutics.com) location in California, United States , revenue, industry and description. Find related and similar companies as well …See details»
Perfuse Therapeutics - Org Chart, Teams, Culture & Jobs - The Org
View Perfuse Therapeutics' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Perfuse Therapeutics - VentureRadar
Website: http://perfusetherapeutics.com/ Develops innovative biotechnology solutions for enhancing retinal perfusion, targeting retinal diseases, primarily focusing ...See details»
Perfuse Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore Perfuse Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 2 clinical trials, 4 news, Disease Domain:Endocrinology and ...See details»
Team - Perfuse Therapeutics
Michelle joined Perfuse in 2021 as the head of clinical development and translational sciences at Perfuse. She is a skilled clinical and translational leader with significant experience in ocular …See details»
Perfuse Therapeutics - Company Profile - Tracxn
Feb 20, 2025 Website: perfusetherapeutics.com; Email ID: *****@perfusetherapeutics.com; Key Metrics. Latest Funding Round. Series A, Jul 2020, Undisclosed. Investors. Access Industries …See details»
Perfuse Therapeutics Overview | SignalHire Company Profile
Perfuse Therapeutics is a private company that has been in the industry for 5 years. The company currently specializes in the Biotechnology, Biotechnology, Pharmaceuticals areas. The position …See details»
Perfuse Therapeutics Information - RocketReach
Perfuse Therapeutics is a clinical-stage biopharmaceutical company committed to reducing the incidence of blindness. Our mission is to develop novel therapeutics to protect and improve …See details»
Perfuse Therapeutics - LinkedIn
Perfuse Therapeutics is a clinical-stage biopharmaceutical company committed to reducing the incidence of blindness. Our mission is to develop novel therapeutics to protect and improve …See details»
Perfuse Therapeutics - VentureRadar
"Perfuse Therapeutics, Inc. is pursuing a novel mechanism to improve retinal perfusion, thereby slow the disease progression in glaucoma, non-proliferative diabetic retinopathy and retinal …See details»
Perfuse Therapeutics, Inc.:Company Profile & Technical Research ...
Perfuse Therapeutics, Inc. is a company that provides Biotechnology, Perfusion and more. Perfuse Therapeutics, Inc. is headquartered in United States California.See details»
Perfuse Therapeutics Announces Positive Visual, Structural and …
Mar 3, 2025 Headquartered in South San Francisco, California and with R&D facilities in Durham, North Carolina, Perfuse Therapeutics has established a strong team committed to …See details»
Perfuse Therapeutics | Catalio Capital Management
Perfuse Therapeutics is a seed-stage biotechnology company focusing on improving retinal perfusion with a novel mechanism. Perfuse is developing therapies for several retinal diseases …See details»
Our Approach - Perfuse Therapeutics
Endothelin signaling is a key regulator of blood vessel tone. Endothelin is the strongest vasoconstrictor in the human body, and excess levels result in decreased blood flow and cell …See details»
Pipeline - Perfuse Therapeutics
Diabetic retinopathy (DR) is a complication of diabetes, associated with reduced blood flow in the retina (retinal non-perfusion, RNP). RNP leads to cell death as well as compensatory changes …See details»